Evidence map›Paper›PMID 36059248›Full record

ArticleEMBO molecular medicine2022

In situ mass spectrometry imaging reveals heterogeneous glycogen stores in human normal and cancerous tissues.

Lyndsay E A Young, Lindsey R Conroy, Harrison A Clarke, Tara R Hawkinson, Kayli E Bolton, William C Sanders, Josephine E Chang, Madison B Webb, Warren J Alilain, Craig W Vander Kooi and 7 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Mass Spectrometry-Based Spatial Imaging of the Cochlea.Journal of the American Society for Mass Spectrometry · 2026
    Article
  5. Mapping glycogen accumulation and treatment effect in Pompe disease with saturation transfer MRI.Translational research : the journal of laboratory and clinical medicine · 2026
    Article
  6. Spatial Molecular Imaging of the Glycome Using Mass Spectrometry.Journal of visualized experiments : JoVE · 2025
    Article
  7. Article
  8. Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  9. Article
  10. Experimental and therapeutic medicine · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The multifaceted roles of the brain glycogen.Journal of neurochemistry · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Lyndsay E A Young *Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.ORCID 0000-0002-6873-5674
Lindsey R Conroy *Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Harrison A ClarkeDepartment of Neuroscience, College of Medicine, University of Kentucky, Lexington, KY, USA.
Tara R HawkinsonDepartment of Neuroscience, College of Medicine, University of Kentucky, Lexington, KY, USA.ORCID 0000-0002-8743-5503
Kayli E BoltonDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.ORCID 0000-0002-5376-4325
William C SandersDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.
Josephine E ChangDepartment of Neuroscience, College of Medicine, University of Kentucky, Lexington, KY, USA.
Madison B WebbDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.
Warren J AlilainDepartment of Neuroscience, College of Medicine, University of Kentucky, Lexington, KY, USA.ORCID 0000-0003-4502-8878
Craig W Vander KooiDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.
Richard R DrakeCell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
Douglas A AndresDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.
Tom C BadgettPediatric Hematology-Oncology, College of Medicine, University of Kentucky, Lexington, KY, USA.
Lars M WagnerPediatric Hematology-Oncology, Duke University, Durham, NC, USA.ORCID 0000-0003-4717-9960
Derek B AllisonDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Kentucky, Lexington, KY, USA.ORCID 0000-0002-5119-2474
Ramon C SunMarkey Cancer Center, University of Kentucky, Lexington, KY, USA.ORCID 0000-0002-3009-1850
Matthew S GentryDepartment of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY, USA.ORCID 0000-0001-5253-9049
University of Kentucky · USDuke University · USMedical University of South Carolina · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Suppressing glycogen storage with small molecule inhibitors as a therapeutic approach to Lafora DiseaseP01NS097197 · NINDS · UNIVERSITY OF KENTUCKY · PI GAO, TIANYAN · 2016 to 2021
$9.0M
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic PotentialR35NS116824 · NINDS · UNIVERSITY OF KENTUCKY · PI Matthew S. Gentry · 2020 to 2026
$8.2M
Deciphering the Glycan Code in Human Alzheimer’s Disease BrainR01AG078702 · NIA · UNIVERSITY OF KENTUCKY · PI Peggi M Angel, Sean Curtis Bendall · 2022 to 2026
$3.8M
Interdisciplinary Research Training in Cancer BiologyT32CA165990 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers, KATHLEEN L. O'CONNOR · 2013 to 2026
$3.2M
Regulation of Neuronal Survival by the Rit GTPaseR01NS045103 · NINDS · UNIVERSITY OF KENTUCKY · PI ANDRES, DOUGLAS ALLEN · 2003 to 2012
$2.7M
Aberrant Glycogen in Lung Adenocarcinoma TumorigenesisR01CA266004 · NCI · UNIVERSITY OF KENTUCKY · PI Matthew S. Gentry, Ramon C. Sun · 2022 to 2026
$2.6M
RIT1-mediated Protection following Traumatic Brain InjuryR01NS102196 · NINDS · UNIVERSITY OF KENTUCKY · PI ANDRES, DOUGLAS ALLEN · 2018 to 2022
$2.5M
Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's DiseaseR01AG066653 · NIA · UNIVERSITY OF KENTUCKY · PI SUN, RAMON C. · 2020 to 2024
$1.9M
Investigating Lung Injury After Cervical Spinal Cord InjuryR21NS121966 · NINDS · UNIVERSITY OF KENTUCKY · PI ALILAIN, WARREN JOSEPH · 2021 to 2021
$421k
Aberrant Glycogen Modulates Metabolism in Ewing’s SarcomaF99CA264165 · NCI · UNIVERSITY OF KENTUCKY · PI YOUNG, LYNDSAY E A · 2021 to 2022
$79k
NCI NIH HHS F99 CA264165NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA266004NCI NIH HHS T32 CA165990NIA NIH HHS R01 AG066653NINDS NIH HHS P01 NS097197NINDS NIH HHS R01 NS045103NINDS NIH HHS R01 NS102196NINDS NIH HHS R21 NS121966NINDS NIH HHS R35 NS116824
6 · The paper itself

Abstract

Glycogen dysregulation is a hallmark of aging, and aberrant glycogen drives metabolic reprogramming and pathogenesis in multiple diseases. However, glycogen heterogeneity in healthy and diseased tissues remains largely unknown. Herein, we describe a method to define spatial glycogen architecture in mouse and human tissues using matrix-assisted laser desorption/ionization mass spectrometry imaging. This assay provides robust and sensitive spatial glycogen quantification and architecture characterization in the brain, liver, kidney, testis, lung, bladder, and even the bone. Armed with this tool, we interrogated glycogen spatial distribution and architecture in different types of human cancers. We demonstrate that glycogen stores and architecture are heterogeneous among diseases. Additionally, we observe unique hyperphosphorylated glycogen accumulation in Ewing sarcoma, a pediatric bone cancer. Using preclinical models, we correct glycogen hyperphosphorylation in Ewing sarcoma through genetic and pharmacological interventions that ablate in vivo tumor growth, demonstrating the clinical therapeutic potential of targeting glycogen in Ewing sarcoma.

Indexed as

Bone NeoplasmsOsteosarcomaSarcoma, EwingAnimalsChildGlycogenHumansMaleMiceSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationGlycogenEwing sarcomaglycogenglycogen storage diseaseMALDI imagingspatial metabolism

Identifiers

PMID36059248
PMCPMC9641418
OpenAlexW4294579015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.